Caliper Life Sciences receives patent for biophotonic imaging tech

Caliper Life Sciences has achieved patent covering for its biophotonic in vivo imaging methods.

The drug discovery and life sciences research specialist states the new patent will cover the use of conjugates consisting of any biocompatible entity and a light source.

It adds that the patent will cover new innovations in biophotonic imaging such as methods based on light sources that are conjugated with a biocompatible entity and administered to mammals.

Kevin Hrusovsky, chief executive officer of Caliper Life Sciences, commented: "In addition to providing researchers with the option to track disease states in an animal without requiring genetic modification of the animal to produce light, the methods covered by the new patent, which encompass a broad range of biophotonic imaging with conjugated probes, are particularly attractive for translation of pre-clinical applications and results into clinical settings."

He added that the patent will extend Caliper’s leadership position in the biophotonic imaging market.

Last month, Caliper Life Sciences announced an agreement with Monogram Biosciences to licence a microfluidics patent portfolio.